UnicoCell Biomed Co (TPE:6794) EBIT per Share : NT$-1.94 (TTM As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is UnicoCell Biomed Co EBIT per Share?

UnicoCell Biomed Co's EBIT per Share for the six months ended in Jun. 2024 was NT$-1.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-1.94.

During the past 3 years, the average EBIT per Share Growth Rate was 16.80% per year. During the past 5 years, the average EBIT per Share Growth Rate was 15.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for UnicoCell Biomed Co's EBIT per Share or its related term are showing as below:

TPE:6794' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -33.4 Med: 14.6 Max: 18.4
Current: 16.8

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of UnicoCell Biomed Co was 18.40% per year. The lowest was -33.40% per year. And the median was 14.60% per year.

TPE:6794's 3-Year EBIT Growth Rate is ranked better than
69.52% of 1250 companies
in the Biotechnology industry
Industry Median: 2.8 vs TPE:6794: 16.80

UnicoCell Biomed Co's EBIT for the six months ended in Jun. 2024 was NT$-56.72 Mil.

UnicoCell Biomed Co EBIT per Share Historical Data

The historical data trend for UnicoCell Biomed Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UnicoCell Biomed Co EBIT per Share Chart

UnicoCell Biomed Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-3.26

-3.03

-2.26

-2.17

-1.54

UnicoCell Biomed Co Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT per Share	Get a 7-Day Free Trial								-0.96	-1.20	-0.62	-0.94	-1.01

UnicoCell Biomed Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

UnicoCell Biomed Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-82.656	/	53.784
=	-1.54

UnicoCell Biomed Co's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-56.72	/	56.353
=	-1.01

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-1.94

UnicoCell Biomed Co (TPE:6794) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

UnicoCell Biomed Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of UnicoCell Biomed Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

UnicoCell Biomed Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » UnicoCell Biomed Co Ltd (TPE:6794) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Minquan East Road, 5th Floor, No. 13-20, Section 6, Neihu District, Taipei, TWN, 11494

Website

https://www.unicocell.com

UnicoCell Biomed Co Ltd is a biotechnology company. Its main business includes new drug R&D and human tissue-derived stem cell inspection and testing, extraction, storage, and technology R&D.

UnicoCell Biomed Co Headlines

No Headlines